
Hathal Haddad/LinkedIn
May 11, 2025, 09:58
Hathal Haddad: Honored to Moderate the Breast and Prostate Brachytherapy Session at ESTRO25
Hathal Haddad, Head of Interventional Radiotherapy Unit of the Department of Radiation Oncology at Tübingen University Hospital, shared a post on LinkedIn:
“Honored to moderate the Breast and Prostate Brachytherapy Session at ESTRO25 with Cristina Guitierrez Miguelez from Spain
It was a pleasure to lead an excellent session highlighting advancements in breast and prostate brachytherapy, with outstanding presentations from esteemed colleagues:
Patient selection for APBI – Updated GEC-ESTRO recommendations
Csaba Polgar, Hungary | E25-3026
Local treatment of ipsilateral breast recurrences – 10-year comparative results
Viktor Smanykó, Hungary | E25-835
MR-assisted focal salvage HDR-BT – updated prospective results
Hans Chung, Canada | E25-3203
20-year outcomes: LDR vs HDR boost in prostate cancer
Alai Goñi Ramirez, Spain | E25-140
Electromagnetic tracking in intraoperative HDR-BT
Ioannis Androulakis, The Netherlands | E25-3797
ESTRO-Elekta Brachytherapy Award Presentation
Christopher Dürrbeck, Germany | E25-3093
ESTRO-ELETA Award: Presented by Maarten ter Mors, The Netherlands
Congratulations to all speakers for their valuable contributions to the field of interventional radiation oncology.”
More posts featuring ESTRO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 11, 2025, 09:27
May 11, 2025, 09:19
May 11, 2025, 09:13
May 11, 2025, 08:22